Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2659

Actual shortage: 251 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2399 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-18 2021-05-13 134343
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135974
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135977
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135980
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-08 2021-05-13 137185
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-05 2021-09-02 143722
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2021-08-27 2021-11-11 144755
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-09 2021-12-08 145446
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-09-16 2021-11-11 145791
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-MORPHINE SR 200MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-10-29 160448
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-12-15 160454
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-01 2023-02-09 176854

Showing 2581 to 2600 of 2659

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353

Showing 21 to 40 of 250